ALYSSA COOK: Open Payments
NPI 1558575175 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 10 payments from 8 companies in 2025. Trend: 2023 $441 · 2024 $104 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $55 |
| Incyte Corporation | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $37 |
| Lilly USA, LLC | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Genentech USA, Inc. | 1 | $26 |
| SERVIER PHARMACEUTICALS LLC | 1 | $25 |
Products named: IMFINZI, ICLUSIG, VERZENIO, KISQALI, Onivyde, Polivy, MONJUVI, Voranigo.
Industry payments across CA — which companies pay providers there.
